Some of the major players operating in the vascular closure device market include
Scion BioMedical
Abbott
Terumo Corporation
Cardinal Health, Inc.
Medtronic plc
Teleflex Incorporated
TZ Medical
Tricol Biomedical
Advanced Vascular Dynamics
Cardiva Medical Inc.
Marine Polymer Technologies
Authors:
Mariam Faizullabhoy , Shishanka Wangnoo
Frequently Asked Questions (FAQ) :
Vascular closure devices industry was valued at USD 1.5 billion in 2022 and is poised to depict 6.5% CAGR from 2023 to 2032 owing to the increasing number of patients suffering from cardiovascular diseases worldwide.
Active segment is expected to witness tremendous growth and reach USD 1.8 billion by 2032 due to the rising preference for minimally invasive procedures in interventional radiology and cardiology.
North America vascular closure device market size generated more than USD 689 million in revenue in 2022 and is estimated to witness notable CAGR from 2023-2032 owing to the increasing prevalence of cardiovascular illnesses and the availability of advanced healthcare infrastructure.
Some of the key vascular closure device companies include Scion BioMedical, Abbott, Terumo Corporation, Cardinal Health, Inc., Medtronic, plc, Teleflex Incorporated, TZ Medical, Tricol Biomedical, Cardiva Medical Inc., and Marine Polymer Technologies.